Results 181 to 190 of about 53,318 (258)
Inhibition of FXa could be a novel therapeutic target associated with hypoxia-associated tumor behavior? [PDF]
Bayrak O, Mert N, Basbinar Y, Bayrak S.
europepmc +1 more source
Rivaroxaban compared to no treatment in ER-negative stage I–III early breast cancer patients (the TIP Trial): study protocol for a phase II preoperative window-of-opportunity study design randomised controlled trial [PDF]
John Castle +10 more
openalex +1 more source
Real-World Comparative Study of Ultra-Low-Dose Rivaroxaban in Very Elderly Patients with Atrial Fibrillation. [PDF]
Han D, Ni Q, Qi J, Ni H, Wang B.
europepmc +1 more source
2 cases of pegylated asparaginase-associated cerebral venous sinus thrombosis in children: clinical analysis and literature review. [PDF]
Chen M, Lu G, Huang Y, Hu Z.
europepmc +1 more source
Impact of different doses of rivaroxaban on clinical outcomes in elderly patients with non-valvular atrial fibrillation: a real-world study. [PDF]
Yu J +6 more
europepmc +1 more source

